Literature DB >> 1467383

EEG coherence in unmedicated schizophrenic patients: topographical study of predominantly never medicated cases.

Y Nagase1, Y Okubo, M Matsuura, T Kojima, M Toru.   

Abstract

Electroencephalographic (EEG) power and coherence were compared in 11 unmedicated schizophrenics (including 9 never mediated patients) and in 15 normal controls. There was no significant difference in power between the two groups. However, interhemispheric coherence between O1-O2 was higher in the schizophrenics in the delta and beta bands, and interhemispheric coherence between T5-T6 was higher in the delta band. These results suggest that coherence is more sensitive than power for comparison of these two groups, and that cerebral function is less lateralized in schizophrenics.

Entities:  

Mesh:

Year:  1992        PMID: 1467383     DOI: 10.1016/0006-3223(92)90064-7

Source DB:  PubMed          Journal:  Biol Psychiatry        ISSN: 0006-3223            Impact factor:   13.382


  12 in total

1.  Resting state EEG power and coherence abnormalities in bipolar disorder and schizophrenia.

Authors:  Julia W Y Kam; Amanda R Bolbecker; Brian F O'Donnell; William P Hetrick; Colleen A Brenner
Journal:  J Psychiatr Res       Date:  2013-09-20       Impact factor: 4.791

2.  Modeling GABA alterations in schizophrenia: a link between impaired inhibition and altered gamma and beta range auditory entrainment.

Authors:  Dorea Vierling-Claassen; Peter Siekmeier; Steven Stufflebeam; Nancy Kopell
Journal:  J Neurophysiol       Date:  2008-02-20       Impact factor: 2.714

3.  EEG alpha coherence and psychopathological dimensions of schizophrenia.

Authors:  John P John; Sumant Khanna; N Pradhan; C R Mukundan
Journal:  Indian J Psychiatry       Date:  2002-04       Impact factor: 1.759

4.  Quantitative EEG analysis at rest and during photic stimulation in drug-naive patients with first-episode paranoid schizophrenia.

Authors:  Y Wada; Y Takizawa; S Kitazawa; Z Y Jiang; N Yamaguchi
Journal:  Eur Arch Psychiatry Clin Neurosci       Date:  1994       Impact factor: 5.270

5.  Sleep spindle activity in childhood onset schizophrenia: Diminished and associated with clinical symptoms.

Authors:  Andjela Markovic; Ashura Buckley; David I Driver; Diane Dillard-Broadnax; Peter A Gochman; Kerstin Hoedlmoser; Judith L Rapoport; Leila Tarokh
Journal:  Schizophr Res       Date:  2020-09-24       Impact factor: 4.939

6.  Gamma and delta neural oscillations and association with clinical symptoms under subanesthetic ketamine.

Authors:  L Elliot Hong; Ann Summerfelt; Robert W Buchanan; Patricio O'Donnell; Gunvant K Thaker; Martin A Weiler; Adrienne C Lahti
Journal:  Neuropsychopharmacology       Date:  2009-11-04       Impact factor: 7.853

Review 7.  Psychosis related to neurological conditions: pro and cons of the dis- / mis-connectivity models of schizophrenia.

Authors:  Jack R Foucher; David Luck
Journal:  Dialogues Clin Neurosci       Date:  2006       Impact factor: 5.986

8.  Altered resting-state EEG source functional connectivity in schizophrenia: the effect of illness duration.

Authors:  Giorgio Di Lorenzo; Andrea Daverio; Fabiola Ferrentino; Emiliano Santarnecchi; Fabio Ciabattini; Leonardo Monaco; Giulia Lisi; Ylenia Barone; Cherubino Di Lorenzo; Cinzia Niolu; Stefano Seri; Alberto Siracusano
Journal:  Front Hum Neurosci       Date:  2015-05-05       Impact factor: 3.169

9.  Dysconnection topography in schizophrenia revealed with state-space analysis of EEG.

Authors:  Mahdi Jalili; Suzie Lavoie; Patricia Deppen; Reto Meuli; Kim Q Do; Michel Cuénod; Martin Hasler; Oscar De Feo; Maria G Knyazeva
Journal:  PLoS One       Date:  2007-10-24       Impact factor: 3.240

10.  Functionally aberrant electrophysiological cortical connectivities in first episode medication-naive schizophrenics from three psychiatry centers.

Authors:  Dietrich Lehmann; Pascal L Faber; Roberto D Pascual-Marqui; Patricia Milz; Werner M Herrmann; Martha Koukkou; Naomi Saito; Georg Winterer; Kieko Kochi
Journal:  Front Hum Neurosci       Date:  2014-08-20       Impact factor: 3.169

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.